Origin & tradition
Not traditional as a supplement: carnosine is abundant in muscle and brain and its anti-aging properties were first studied in Russia.
Western tradition · Dipeptide
Carnosine
An endogenous dipeptide that chelates metals, quenches reactive carbonyls, and inhibits protein glycation — key anti-aging mechanisms.
53ClinicalTrials.gov matched
158PubMed RCT records
41Meta-analysis records
2+PubMed records
L-CarnosineKey active compound
Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.
Why longevity buyers care
Key active: L-Carnosine (β-alanyl-L-histidine dipeptide).
Carnosine is a histidyl dipeptide that acts as a non-enzymatic antioxidant, heavy-metal chelator, and anti-glycation agent (reacting with reactive carbonyls before they crosslink proteins). Carnosine levels decline ~60% from youth to old age. Human trials cover exercise fatigue (via beta-alanine precursor), glycemic control, and cognitive aging.
Effect summary
Studied health outcomes
Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Glycation / AGE formation | Decreases | Minor | C |
| Cognitive function (elderly) | Increases | Minor | C |
| Muscle buffering / exercise capacity — Beta-alanine is more efficient than carnosine for this purpose | Increases | Minor | C |
| Antioxidant activity | Increases | Minor | C |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
How Carnosine is typically used
- Typical dose
- 500–2,000 mg/day
- Form
- capsule
- Timing
- any time, with or without food
Carnosine is a dipeptide (beta-alanine + histidine) that acts as an intracellular buffer and anti-glycation agent. It is rapidly broken down by carnosinase in blood — sustained release or repeated dosing is important. Beta-alanine supplementation raises muscle carnosine more efficiently.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
What the research actually says
72Evidence confidence
Extensive human-trial evidence158 randomized controlled trials · 41 meta-analyses / systematic reviews
Mechanistic + small human trials; aging-specific RCTs limited
Carnosine is a histidyl dipeptide that acts as a non-enzymatic antioxidant, heavy-metal chelator, and anti-glycation agent (reacting with reactive carbonyls before they crosslink proteins). Carnosine levels decline ~60% from youth to old age. Human trials cover exercise fatigue (via beta-alanine precursor), glycemic control, and cognitive aging.
53registered clinical trials reference this intervention
0selected from 2+ PubMed papers (longevity / aging angle)
Key active: L-Carnosine (β-alanyl-L-histidine dipeptide).
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-09-13. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Carnosine appears in
Suppliers
No Carnosine suppliers listed yet
Tell us what you need and we will source suppliers for you.